Dynavax Technologies | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q4 Dec/2025 0.04 0.05 Feb/19 2026
FY2025Q3 Sep/2025 0.21 0.13 0.12 Nov/05 2025
FY2025Q2 Jun/2025 0.14 0.10 0.08 Aug/07 2025
FY2025Q1 Mar/2025 -0.77 0.01 -0.07 May/06 2025
FY2024Q4 Dec/2024 0.05 0.04 0.0 Feb/20 2025




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Adma Biologics USD 0.15 0.01 2025-09
Agenus USD -1.03 1.01 2025-03
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.12 1.32 2025-09
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Dynavax Technologies USD 0.21 0.07 2025-09
Gilead Sciences USD 1.86 0.61 2025-12
Glaxosmithkline GBP 0.72 0.37 2025-09
Merck USD 2.04 0.54 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 2.04 0.38 2025-09
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sarepta Therapeutics USD -0.13 2.15 2025-09
TG Therapeutics USD 2.43 2.26 2025-09
Vertex Pharmaceuticals USD 4.8 0.28 2025-09


Dynavax Technologies Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.